Jadenu Sprinkle Interactions
There are 598 drugs known to interact with Jadenu Sprinkle (deferasirox), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 206 are major, 379 are moderate, and 13 are minor.
- View all 598 medications that may interact with Jadenu Sprinkle
- View Jadenu Sprinkle alcohol/food interactions (2)
- View Jadenu Sprinkle disease interactions (6)
Most frequently checked interactions
View interaction reports for Jadenu Sprinkle (deferasirox) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- Aldurazyme (laronidase)
- Amicar (aminocaproic acid)
- Arava (leflunomide)
- Aricept (donepezil)
- Austedo (deutetrabenazine)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Braftovi (encorafenib)
- Cathflo Activase (alteplase)
- Cymbalta (duloxetine)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Jynarque (tolvaptan)
- Ofev (nintedanib)
- Prolixin (fluphenazine)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tamiflu (oseltamivir)
- Tecfidera (dimethyl fumarate)
- Thorazine (chlorpromazine)
- Yescarta (axicabtagene ciloleucel)
Jadenu Sprinkle alcohol/food interactions
There are 2 alcohol/food interactions with Jadenu Sprinkle (deferasirox).
Jadenu Sprinkle disease interactions
There are 6 disease interactions with Jadenu Sprinkle (deferasirox) which include:
- bone marrow suppression
- dermatologic toxicities
- hepatic impairment
- renal dysfunction
- auditory and ocular abnormalities
- GI complication
More about Jadenu Sprinkle (deferasirox)
- Jadenu Sprinkle consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.